129 related articles for article (PubMed ID: 21299977)
1. Mitochondrial dysfunction and neurodegenerative diseases.
Byvaltsev V; Sudakov N; Nikiforov S; Konstantinov Y
World Neurosurg; 2010 Jul; 74(1):10-2. PubMed ID: 21299977
[No Abstract] [Full Text] [Related]
2. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.
Trushina E; McMurray CT
Neuroscience; 2007 Apr; 145(4):1233-48. PubMed ID: 17303344
[TBL] [Abstract][Full Text] [Related]
3. Axonal transport failure in neurodegenerative disorders: the case of Huntington's disease.
Charrin BC; Saudou F; Humbert S
Pathol Biol (Paris); 2005 May; 53(4):189-92. PubMed ID: 15850950
[No Abstract] [Full Text] [Related]
4. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
5. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
6. Combined expression of tau and the Harlequin mouse mutation leads to increased mitochondrial dysfunction, tau pathology and neurodegeneration.
Kulic L; Wollmer MA; Rhein V; Pagani L; Kuehnle K; Cattepoel S; Tracy J; Eckert A; Nitsch RM
Neurobiol Aging; 2011 Oct; 32(10):1827-38. PubMed ID: 19942317
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial dysfunction in Huntington's disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice.
Oliveira JM; Jekabsons MB; Chen S; Lin A; Rego AC; Gonçalves J; Ellerby LM; Nicholls DG
J Neurochem; 2007 Apr; 101(1):241-9. PubMed ID: 17394466
[TBL] [Abstract][Full Text] [Related]
8. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease.
Lee WC; Yoshihara M; Littleton JT
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial disorders in the nervous system.
DiMauro S; Schon EA
Annu Rev Neurosci; 2008; 31():91-123. PubMed ID: 18333761
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial medicine for aging and neurodegenerative diseases.
Reddy PH
Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of endoplasmic reticulum stress counteracts neuronal cell death and protein aggregation caused by N-terminal mutant huntingtin proteins.
Reijonen S; Putkonen N; Nørremølle A; Lindholm D; Korhonen L
Exp Cell Res; 2008 Mar; 314(5):950-60. PubMed ID: 18255062
[TBL] [Abstract][Full Text] [Related]
12. News from the powerhouses.
Frank S; Tolnay M
Acta Neuropathol; 2012 Feb; 123(2):155-6. PubMed ID: 22179602
[No Abstract] [Full Text] [Related]
13. Mitochondrial impairment in patients and asymptomatic mutation carriers of Huntington's disease.
Saft C; Zange J; Andrich J; Müller K; Lindenberg K; Landwehrmeyer B; Vorgerd M; Kraus PH; Przuntek H; Schöls L
Mov Disord; 2005 Jun; 20(6):674-9. PubMed ID: 15704211
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial dysfunction, oxidative stress, regulation of exocytosis and their relevance to neurodegenerative diseases.
Keating DJ
J Neurochem; 2008 Jan; 104(2):298-305. PubMed ID: 17961149
[TBL] [Abstract][Full Text] [Related]
15. An overview of the pathophysiology of neurodegenerative disorders.
Willner C
Altern Ther Health Med; 2004; 10(4):26-34; quiz 35, 96. PubMed ID: 15285272
[No Abstract] [Full Text] [Related]
16. LKB1-regulated adaptive mechanisms are essential for neuronal survival following mitochondrial dysfunction.
Germain M; Nguyen AP; Khacho M; Patten DA; Screaton RA; Park DS; Slack RS
Hum Mol Genet; 2013 Mar; 22(5):952-62. PubMed ID: 23187960
[TBL] [Abstract][Full Text] [Related]
17. Brief update on different roles of tau in neurodegeneration.
Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial abnormalities in muscle and other aging cells: classification, causes, and effects.
DiMauro S; Tanji K; Bonilla E; Pallotti F; Schon EA
Muscle Nerve; 2002 Nov; 26(5):597-607. PubMed ID: 12402281
[TBL] [Abstract][Full Text] [Related]
19. Disruption of cellular transport: a common cause of neurodegeneration?
Crosby AH
Lancet Neurol; 2003 May; 2(5):311-6. PubMed ID: 12849185
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress and neurodegeneration: where are we now?
Halliwell B
J Neurochem; 2006 Jun; 97(6):1634-58. PubMed ID: 16805774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
